Myriad Genetics, Inc.

Symbol: MYGN

NASDAQ

21.6

USD

Markedspris i dag

-7.5210
P/E-forhold
-0.4011
PEG Ratio
1.94B
MRK Cap
0.00%
DIV Udbytte

Myriad Genetics, Inc. (MYGN) Årsregnskaber

Q: Hvad er Myriad Genetics, Inc. (MYGN) samlede aktiver?

Myriad Genetics, Inc. (MYGN) samlede aktiver er .

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Myriad Genetics, Inc. (MYGN). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Myriad Genetics, Inc., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	114.9	339.8	136.9	136.9	180.6	150.7	159	144.8	270.6	531.1	454.2	346.5	403.2	316.9	328.7	308.3	227.7	113.8	115.4	72.8	73.1	127.2	80.5	9.9	14.6	15.7	13.2
balance-sheet.row.short-term-investments	58	81.4	43.7	43.7	69.7	48.3	90.5	80.7	121.6	268.2	254.2	293.8	310.4	253.3	91	164.9	129.2	64.3	31.4	11.2	12	91.3	24.3	4.5	0	0	0
balance-sheet.row.net-receivables	101.6	91.3	138.6	138.6	102.1	111.3	95	87.7	98.7	97.7	63.1	50.3	48.1	45.3	45.4	32.5	22.2	18.4	14.5	22.3	7.5	5.8	2.8	3.2	0.6	0.5	0
balance-sheet.row.inventory	20.1	15.3	31.4	31.4	34.3	42.2	38.3	25.1	23.9	5	11.6	5.7	-399.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	20.4	38.4	41.7	46.4	9.4	12.9	22.2	26	27	9	7.3	417.9	488.4	4	3.1	2.5	2.3	3.3	7.3	7.7	4.8	4.2	2.7	0.6	16.5	32.4	37.4
balance-sheet.row.total-current-assets	274.6	484.8	348.6	348.6	326.4	317.1	314.5	283.6	400.1	634.7	530.6	479.3	540.6	366.2	377.3	343.3	252.3	135.6	137.2	102.8	85.4	137.2	85.9	13.7	31.7	48.6	50.6
balance-sheet.row.property-plant-equipment-net	187.3	125.3	57.3	57.3	43.2	51.1	58.3	67.2	34.6	27.6	24.2	23.1	23.3	22.6	30	24.9	19.8	18.5	17.3	18.7	15.4	12.7	11.3	10	12.4	12	9.4
balance-sheet.row.goodwill	286.8	239.2	417.2	417.2	318.6	316.1	195.3	177.2	169.2	56.9	56.9	56.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	379.7	404.1	684.7	684.7	455.2	491.6	227.5	192.6	205.3	13.3	15.7	16.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	666.5	643.3	1101.9	1101.9	773.8	807.7	422.8	369.8	374.5	70.2	72.6	72.8	-85.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	54.8	59	54.9	54.9	30.7	48.5	79.9	40.6	84.1	158.7	113.7	70.9	85.2	75.4	91.3	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	9.6	36.6	36.2	35.7	28	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	15.5	8.3	0	-1214.1	0	0	5	5	-79.1	-124.1	-86.7	-70.9	2.1	2.3	0.7	3.9	4.5	4.9	33.8	61.3	56.6	22.2	9.2	29.9	23.3	15.5	19.6
balance-sheet.row.total-non-current-assets	924.1	835.9	1214.1	1214.1	847.7	907.3	566	482.6	423.7	169.1	160	131.5	53.3	100.3	122	28.8	24.3	23.4	51.2	80	72	34.9	20.4	39.9	35.7	27.5	29
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1198.7	1320.7	1562.7	1562.7	1174.1	1224.4	880.5	766.2	823.8	803.8	690.6	610.8	593.8	466.4	499.3	372.1	276.6	159	188.4	182.8	157.4	172.1	106.4	53.6	67.4	76.1	79.6
balance-sheet.row.account-payables	28.8	29.6	33.3	33.3	26	22	21.1	21.1	23.1	18.1	10.1	11.4	8.9	14.2	24.9	15.8	11.8	11.9	7.9	11.5	9.5	9.7	4.3	2.9	5.1	2.6	2.2
balance-sheet.row.short-term-debt	14.1	13	78.9	78.9	68.3	65.6	0	0	0	0	0	9.6	0	0	0	0	0	0	0	0	3.6	0	0	0	0.1	0.3	0.3
balance-sheet.row.tax-payables	4.8	4	3	3	4.3	7.1	2.8	3.8	277.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	130.9	79.3	233.5	233.5	9.3	99.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.5
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	93.7	156.5	3.4	82.3	5.3	127.3	49.5	46.1	56.4	44.3	32.8	21.6	27.4	18	46.8	15.6	14.9	10.1	5.9	4.9	1	3.1	24.4	2.4	4.7	6.9	6.5
balance-sheet.row.total-non-current-liabilities	175.7	148.6	356	356	107	229.1	60.1	35.4	24.2	10.7	10	9.6	8.8	14.2	26.9	16.1	11.9	13.1	9.1	14.4	23.9	29.5	4.3	0.1	5.2	0.1	0.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	-9.6	-8.8	-14.2	-26.9	-16.1	-11.9	-13.1	-9.1	-14.4	-23.9	-29.5	-4.3	0	-5.2	0	0
balance-sheet.row.capital-lease-obligations	145	92.3	70.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	312.9	352.9	473.8	473.8	209.2	446.6	132.4	104.1	104.8	75.2	55	44	36.3	32.2	73.7	31.7	26.8	23.3	15.1	19.3	28.5	32.6	28.7	5.4	9.9	9.9	9.4
balance-sheet.row.preferred-stock	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.8	0.8	0.9	0.9	1	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0	0	0
balance-sheet.row.retained-earnings	-366.2	-254.2	25.6	25.6	52.8	-68.4	-73.2	-77	2	30.9	-12.7	-38.6	-10.5	-119.9	-204.6	-252.4	-217.4	-179.2	-139.3	-98.7	-73.8	-59.8	-52.7	-43.9	-33.9	-24.1	-14.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-8.9	-5.1	-5.4	-5.4	-4	-5.5	-9.5	-7	-1.5	-0.4	-0.2	0.2	0.1	2.8	-0.2	-0.4	-0.7	-0.5	-0.2	0.7	0.3	0.4	-0.1	-0.3	0	0	0
balance-sheet.row.other-total-stockholders-equity	1260.1	1226.3	1068	1068	915.4	851.4	830.1	745.4	717.8	697.3	647.7	604.4	567	550.4	630	592.7	467.6	315.1	312.5	261.2	202.1	198.8	130.2	92.3	91.4	90.3	85.1
balance-sheet.row.total-stockholders-equity	885.8	967.8	1088.9	1088.9	964.9	778.2	748.1	662.1	719	728.6	635.7	566.8	557.6	434.2	425.7	340.4	249.8	135.7	173.3	163.5	128.9	139.6	77.7	48.2	57.5	66.2	70.2
balance-sheet.row.total-liabilities-and-stockholders-equity	1198.7	1320.7	1562.7	1562.7	1174.1	1224.4	880.5	766.2	823.8	803.8	690.6	610.8	593.8	466.4	499.3	372.1	276.6	159	188.4	182.8	157.4	172.1	106.4	53.6	67.4	76.1	79.6
balance-sheet.row.minority-interest	0	0	0	0	0	-0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-	-	-	1088.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	112.8	140.4	98.6	98.6	100.4	96.8	170.4	121.3	205.8	427	367.9	364.6	395.5	328.7	182.3	164.9	129.2	64.3	31.4	11.2	12	91.3	24.3	4.5	0	0	0
balance-sheet.row.total-debt	145	92.3	233.5	233.5	9.3	99.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.8
balance-sheet.row.net-debt	88.1	-166.1	140.3	140.3	-101.6	-3.3	-68.5	-64.1	-64.8	-104.1	-86.4	-52.7	-92.8	-63.5	-237.7	-143.4	-98.6	-49.5	-84	-61.6	-61.1	-35.9	-56.2	-5.4	-14.5	-15.3	-12.4

Pengestrømsopgørelse

Det økonomiske landskab for Myriad Genetics, Inc. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
cash-flows.row.net-income	-112	-27.2	4.6	4.6	131	21.8	125.3	80.2	176.2	147.1	112.2	100.7	152.3	84.6	47.8	-35	-38.2	-40	-40.6	-24.8	-14	-7.2	-8.7	-10	-9.8	-9.2	-5.9
cash-flows.row.depreciation-and-amortization	52.7	62.8	73	73	54.4	48.3	26.7	25	13.8	8.9	9.1	7.2	7.1	9.4	8.8	7.5	6.9	6.1	5.8	5.3	4.5	3.7	3.3	3.2	3.3	2.5	1.6
cash-flows.row.deferred-income-tax	-31.9	-34.7	13.1	13.1	-23.7	2.5	15.7	1.7	7.5	8.2	34.2	40.4	-28.1	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	38.1	36.3	33.5	33.5	27.1	29.9	31.6	45.7	27.1	26.6	26.3	25.1	22.8	25.7	0	0	-0.2	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-101.5	120.4	-37.1	-37.1	-21.6	-36.6	-65.4	-40.7	-60	-41	-28.8	38.5	-27.4	-54.1	16.9	-11.2	-1.4	6.1	1.9	-27.3	-7.3	-0.7	22.1	-7.5	-0.6	-0.1	5.6
cash-flows.row.account-receivables	-10.3	-8.8	-18.2	-18.2	-39.2	-41.4	-39.2	-34.4	-24.4	-67.2	-34.9	-15	-21.7	-19.9	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-2.9	1.6	8	8	7.9	-1.2	-14.6	-0.8	-15.8	6.6	-3.4	0.2	-0.5	-21.5	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	-3.5	9.2	1.1	1.1	4	-3	-11.4	-3.1	-1.5	8	-1.2	0.3	-5.3	-10.7	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-84.8	118.4	-28	-28	5.7	9	-0.2	-2.4	-18.3	11.6	10.9	53	0	-2	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-non-cash-items	48.3	-139.4	-3.4	-3.4	-51.3	40.3	32.4	28.6	25.6	24.1	-11.1	-81.2	28.4	17.9	30.3	12.7	4.7	4.5	2	0.4	0.5	0.4	0.5	0.2	0.1	0.2	0.1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-45.3	-18	-8.6	-8.6	-8.4	-6.1	-5	-23.9	-14.3	-11.4	-10.2	-5.8	0	-7.5	-13.7	-11.4	-7.7	-6.7	-3.9	-8	-6.9	-5.3	-4.6	-4	-3.2	-4.7	-6.4
cash-flows.row.acquisitions-net	-57.2	379.1	-278.5	-278.5	8.4	-216.1	-37	-20.1	-223.5	-5	-0.8	-79.4	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0
cash-flows.row.purchases-of-investments	-103.2	-147.8	-78.5	-78.5	-80.9	-87.5	-164.5	-80.7	-161.8	-443.8	-396.1	-425.2	-477.6	-308.6	-191.7	-197.8	-165.5	-44.6	-52.7	-51.8	-89.8	-249.3	-24	-291.7	-840.6	-582.8	-622.2
cash-flows.row.sales-maturities-of-investments	128.2	61.1	79.2	79.2	77.7	163.4	115.1	165.6	381.9	384.6	385.2	456.1	52.2	111.8	174.4	162.5	100.5	71	58.6	50.7	137.2	172.2	25	300.2	841.1	592.2	569.6
cash-flows.row.other-investing-activites	0	0	0	0	-8.4	0	0	0	0	0	-17.1	-0.1	348.7	-9.6	-0.3	0	-0.1	-0.1	-0.1	-2.9	-2.5	-2.7	-0.8	0	0	-0.1	0
cash-flows.row.net-cash-used-for-investing-activites	-77.5	274.4	-286.4	-286.4	-11.6	-146.3	-91.4	40.9	-17.7	-75.6	-38.9	-54.4	-76.7	-206.3	-31.3	-46.7	-72.8	19.5	1.9	-12	38.1	-85.1	-4.3	4.5	-2.7	4.7	-59
cash-flows.row.debt-repayment	0	-226.4	-115	-115	-143	-305	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	6.3	91.8	8.7	8.7	36.9	6	0	30	0	0	0	25.1	22.3	84.2	21.9	117.5	149.9	2.5	51.3	59	3.4	68.6	38	0.6	0.6	4.6	59.2
cash-flows.row.common-stock-repurchased	0	0	-50	-50	0	-31.6	-162.6	-210.7	-287.7	-146.3	-128.5	-200.5	-71.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	-340	-340	0	-403	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-14.3	-16	678.6	338.6	11.1	805.4	94.3	3.4	75.9	65.7	59.2	58.8	0	-136.1	0	0	0	0	0	0	0	0	0	-0.2	-0.4	-0.3	-0.3
cash-flows.row.net-cash-used-provided-by-financing-activities	-8	-150.6	182.3	182.3	-95	71.8	-68.3	-177.3	-211.8	-80.6	-69.2	-116.6	-49.1	-51.9	21.9	117.5	149.9	2.5	51.3	59	3.4	68.6	38	0.4	0.2	4.3	58.9
cash-flows.row.effect-of-forex-changes-on-cash	-0.6	-0.6	2.7	2.7	-0.8	2.2	-2.2	-4.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	-14.6	-15.6	-13.2
cash-flows.row.net-change-in-cash	-192.4	141.4	-17.7	-17.7	8.5	33.9	4.4	-0.7	-39.3	17.7	33.7	-40.2	29.3	-174.2	94.3	44.9	49.1	-1.3	22.4	0.5	25.1	-20.3	50.8	-9.2	-24.1	-13.2	-11.9
cash-flows.row.cash-at-end-of-period	66.4	258.4	93.2	93.2	110.9	102.4	68.5	64.1	64.8	104.1	86.4	52.7	92.8	63.5	237.7	143.4	98.6	49.5	84	61.6	61.1	35.9	56.2	5.4	0	0	0
cash-flows.row.cash-at-beginning-of-period	258.8	117	110.9	110.9	102.4	68.5	64.1	64.8	104.1	86.4	52.7	92.8	63.5	237.7	143.4	98.6	49.5	50.8	61.6	61.1	35.9	56.2	5.4	14.6	24.1	13.2	11.9
cash-flows.row.operating-cash-flow	-106.3	18.2	83.7	83.7	115.9	106.2	166.3	140.5	190.2	173.9	141.8	130.8	155.1	84	103.7	-25.9	-28	-23.3	-30.9	-46.5	-16.3	-3.8	17.2	-14.1	-7	-6.6	1.4
cash-flows.row.capital-expenditure	-45.3	-18	-8.6	-8.6	-8.4	-6.1	-5	-23.9	-14.3	-11.4	-10.2	-5.8	0	-7.5	-13.7	-11.4	-7.7	-6.7	-3.9	-8	-6.9	-5.3	-4.6	-4	-3.2	-4.7	-6.4
cash-flows.row.free-cash-flow	-151.6	0.2	75.1	75.1	107.5	100.1	161.3	116.6	175.9	162.5	131.7	125	155.1	76.5	90.1	-37.3	-35.7	-30	-34.8	-54.6	-23.2	-9	12.5	-18.1	-10.2	-11.3	-5

Resultatopgørelse række

Myriad Genetics, Inc.s omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for MYGN rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln USD Growth	2021	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	678.4	690.6	851.1	851.1	772.6	771.4	753.8	723.1	778.2	613.2	496	402.1	362.6	326.5	333.6	157.1	114.3	82.4	56.6	64.3	53.8	45.2	34	25.3	23.2	15.2	6.6
income-statement-row.row.cost-of-revenue	202	197.6	201	201	177.2	171.2	157.3	147.4	109.2	79.6	64.7	46.7	44.3	43.3	32.3	30.8	27.6	20.3	13.8	12.6	10.7	7.4	0.7	-0.1	-1.9	-2.2	-1.6
income-statement-row.row.gross-profit	476.4	493	650.1	650.1	595.4	600.2	596.5	575.7	669	533.5	431.3	355.4	318.4	283.3	301.3	126.3	86.6	62.1	42.9	51.8	43.1	37.8	33.3	25.4	25.1	17.4	8.2
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.6	139.3	1.2	1.2	-0.4	-2.5	1.2	0.3	-2	-0.2	-0.4	0	0	0	0	0	0	0	0	0	0	0	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.operating-expenses	600.1	681.7	641.4	641.4	537.9	550.8	429.7	441.5	394.6	305.5	251	197.6	183.3	156.8	263.2	174	132.2	102.8	85.5	79.1	61.8	50.9	44.9	37.8	38.1	29.9	17.1
income-statement-row.row.cost-and-expenses	802.1	879.3	842.4	842.4	715.1	722	587	588.9	503.8	385.2	315.7	244.3	227.6	200.1	295.5	204.9	159.9	123.2	99.3	91.7	72.5	58.3	45.6	37.7	36.2	27.7	15.5
income-statement-row.row.interest-income	2.6	0.7	3.2	3.2	1.8	1.2	0.9	0.4	5.4	5.5	4.6	2.2	5.7	12.5	13.7	12.1	7.4	2.8	0	2.9	5.4	0	0	0	0	0	0
income-statement-row.row.interest-expense	3.2	6.6	12	12	3.2	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-16.9	-8.4	0.1	0.1	60.8	-1.7	1.2	0.3	-2	-0.2	-0.4	-0.4	0.1	-2.5	-3.3	0.7	0	-2	0	0	-0.2	-0.3	-0.4	12.4	3.2	3.3	3.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.6	139.3	1.2	1.2	-0.4	-2.5	1.2	0.3	-2	-0.2	-0.4	0	0	0	0	0	0	0	0	0	0	0	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.total-operating-expenses	-16.9	-8.4	0.1	0.1	60.8	-1.7	1.2	0.3	-2	-0.2	-0.4	-0.4	0.1	-2.5	-3.3	0.7	0	-2	0	0	-0.2	-0.3	-0.4	12.4	3.2	3.3	3.1
income-statement-row.row.interest-expense	3.2	6.6	12	12	3.2	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	55.9	62.8	73	73	54.4	48.3	26.7	25	13.8	8.9	9.1	7.2	7.1	9.4	8.8	7.5	6.9	6.1	5.8	5.3	4.5	3.7	3.3	3.2	3.3	2.5	1.6
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-123.7	-48.7	7.6	7.6	118.7	49.4	166.8	134.2	274.4	228	180.3	157.8	135.1	126.5	38.1	-47.7	-45.6	-40.7	-42.6	-27.3	-18.7	-13.1	-11.5	-12.4	-13	-12.5	-8.9
income-statement-row.row.income-before-tax	-140.6	-57.1	0.2	7.7	116.9	42.9	168.9	134.9	277.9	233.3	184.5	159.7	140.8	136.4	48.5	-35	-38.2	-40	-40.6	-24.4	-13.5	-6.6	-8.7	-10	-9.8	-9.2	-5.9
income-statement-row.row.income-tax-expense	-28.6	-29.9	-4.4	-4.4	-13.9	21.3	43.6	54.7	101.6	86.1	72.4	58.9	-11.5	0.2	0.6	35	-7.4	-0.8	-2	0.4	0.5	0.6	8.7	10	9.8	9.2	5.9
income-statement-row.row.net-income	-112	-27.2	4.6	4.6	131	21.8	125.3	80.2	176.2	147.1	112.2	100.7	152.3	84.6	47.8	-35	-38.2	-40	-40.6	-24.8	-14	-7.2	-8.7	-10	-9.8	-9.2	-5.9